Detailed information for compound 1757677

Basic information

Technical information
  • TDR Targets ID: 1757677
  • Name: 3-(1,3-benzoxazol-2-yloxy)-1-butyl-4-methylpy ridine-2-thione
  • MW: 314.402 | Formula: C17H18N2O2S
  • H donors: 0 H acceptors: 1 LogP: 4.07 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCCn1ccc(c(c1=S)Oc1nc2c(o1)cccc2)C
  • InChi: 1S/C17H18N2O2S/c1-3-4-10-19-11-9-12(2)15(16(19)22)21-17-18-13-7-5-6-8-14(13)20-17/h5-9,11H,3-4,10H2,1-2H3
  • InChiKey: XARMKWATHNGOHD-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 3-(1,3-benzoxazol-2-yloxy)-1-butyl-4-methyl-pyridine-2-thione
  • 3-(1,3-benzoxazol-2-yloxy)-1-butyl-4-methyl-2-pyridinethione

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens cannabinoid receptor 2 (macrophage) Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Loa Loa (eye worm) CYP4Cod1 0.0017 0.4068 0.4068
Trypanosoma cruzi cytochrome P450, putative 0.0017 0.4068 0.5
Loa Loa (eye worm) cytochrome P450 family protein 0.0017 0.4068 0.4068
Loa Loa (eye worm) cytochrome P450 family protein 0.0028 1 1
Trypanosoma brucei cytochrome P450, putative 0.0017 0.4068 0.5
Mycobacterium ulcerans cytochrome P450 185A4 Cyp185A4 0.0017 0.4068 0.5
Leishmania major cytochrome p450-like protein 0.0017 0.4068 0.5
Trypanosoma cruzi cytochrome P450, putative 0.0017 0.4068 0.5
Loa Loa (eye worm) cytochrome P450 family protein 0.0017 0.4068 0.4068

Activities

Activity type Activity value Assay description Source Reference
Ki (binding) = 235 nM Displacement of [H3]-CP-55940 from human recombinant CB2 receptor expressed in CHO cells ChEMBL. 23395112

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.